Alexion Earnings, Income Beat in Q1 By


© Reuters. Alexion Earnings, Income Beat in Q1 – Alexion (NASDAQ:) reported on Friday first quarter that beat analysts’ forecasts and income that topped expectations.

Alexion introduced earnings per share of $3.52 on income of $1.64B. Analysts polled by anticipated EPS of $3.16 on income of $1.58B.

Alexion shares are up 13% from the start of the yr, nonetheless down 1.74% from its 52 week excessive of $168.51 set on April 21. They’re outperforming the S&P 500 which is up 12.12% from the beginning of the yr.

Alexion shares gained 2.67% in pre-market commerce following the report.

Alexion follows different main Healthcare sector earnings this month

Alexion’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on income of $22.32B, in comparison with forecasts EPS of $2.34 on income of $21.98B.

Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on income of $10.46B, in comparison with forecast for EPS of $1.27 on income of $10.69B.

Keep up-to-date on the entire upcoming earnings stories by visiting’s earnings calendar

Disclaimer: Fusion Media want to remind you that the info contained on this web site is just not essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs aren’t supplied by exchanges however moderately by market makers, and so costs is probably not correct and should differ from the precise market value, that means costs are indicative and never applicable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any duty for any buying and selling losses you would possibly incur on account of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury on account of reliance on the data together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is without doubt one of the riskiest funding varieties doable.

Supply hyperlink

Leave a reply